Atazanavir Sulfate
- Product NDC
- 0904-6875
- 11-digit product format
- 009046875
- Labeler code
- 0904
- Product ID
- 0904-6875_48c772ae-1d3e-4d68-9b98-c35810a0cda0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Atazanavir
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Major Pharmaceuticals
- Application
- ANDA204806
- Marketing category
- ANDA
- Marketing start
- 2018-06-25
- Marketing end
- 0000-00-00
- Substance
- ATAZANAVIR SULFATE
- Active strength
- 300 mg/1
- Pharmacologic classes
- HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0904-6875-04 | 00904687504 | 30 BLISTER PACK in 1 CARTON (0904-6875-04) > 1 CAPSULE in 1 BLISTER PACK | 30 blister pack | 2018-06-25 | 0000-00-00 | No | No | Current |